Chemistry:JWH-371
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C30H33NO |
| Molar mass | 423.600 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
JWH-371 ([5-(4-butylphenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB1 (Ki = 42 ± 1nM) and CB2 (Ki = 64 ± 2nM) receptors, binding ~1.5 times stronger to the CB1 receptor than the CB2 receptor. JWH-371 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB1 receptor.[1]
Legality
In the United States JWH-371 is not federally scheduled, although some states have passed legislation banning the sale, possession, and manufacture of JWH-371.[2][3][4][5]
In Canada, JWH-371 and other naphthoylpyrrole-based cannabinoids are Schedule II controlled substances under the Controlled Drugs and Substances Act.[citation needed]
In the United Kingdom, JWH-371 and other naphthoylpyrrole-based cannabinoids are considered Class B drugs under the Misuse of Drugs Act 1971.[citation needed]
See also
- List of JWH cannabinoids
- Synthetic cannabinoid
References
- ↑ "1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors". Bioorganic & Medicinal Chemistry Letters 16 (20): 5432–5. October 2006. doi:10.1016/j.bmcl.2006.07.051. PMID 16889960.
- ↑ : Schedules of controlled substances
- ↑ "The 2020 Florida Statutes". http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/Sections/0893.03.html.
- ↑ "Arizona Revised Statutes Title 13. Criminal Code § 13-3401". https://www.azleg.gov/ars/13/03401.htm.
- ↑ "California Code, Health and Safety Code - HSC § 11357.5". https://codes.findlaw.com/ca/health-and-safety-code/hsc-sect-11357-5.html.
 |  |
